137 related articles for article (PubMed ID: 29930945)
1. Acute and Chronic Effects of Protein Kinase-D Signaling on Cardiac Energy Metabolism.
Simsek Papur O; Sun A; Glatz JFC; Luiken JJFP; Nabben M
Front Cardiovasc Med; 2018; 5():65. PubMed ID: 29930945
[TBL] [Abstract][Full Text] [Related]
2. Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK.
Luiken JJ; Vertommen D; Coort SL; Habets DD; El Hasnaoui M; Pelsers MM; Viollet B; Bonen A; Hue L; Rider MH; Glatz JF
Cell Signal; 2008 Mar; 20(3):543-56. PubMed ID: 18164589
[TBL] [Abstract][Full Text] [Related]
3. Decoding the Cardiac Actions of Protein Kinase D Isoforms.
Steinberg SF
Mol Pharmacol; 2021 Dec; 100(6):558-567. PubMed ID: 34531296
[TBL] [Abstract][Full Text] [Related]
4. The PKD inhibitor CID755673 enhances cardiac function in diabetic db/db mice.
Venardos K; De Jong KA; Elkamie M; Connor T; McGee SL
PLoS One; 2015; 10(3):e0120934. PubMed ID: 25798941
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase-D1 overexpression prevents lipid-induced cardiac insulin resistance.
Dirkx E; van Eys GJ; Schwenk RW; Steinbusch LK; Hoebers N; Coumans WA; Peters T; Janssen BJ; Brans B; Vogg AT; Neumann D; Glatz JF; Luiken JJ
J Mol Cell Cardiol; 2014 Nov; 76():208-17. PubMed ID: 25173922
[TBL] [Abstract][Full Text] [Related]
6. Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats.
Sack MN; Harrington LS; Jonassen AK; Mjøs OD; Yellon DM
Cardiovasc Drugs Ther; 2000 Feb; 14(1):31-9. PubMed ID: 10755198
[TBL] [Abstract][Full Text] [Related]
7. Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy.
Wang KC; Lim CH; McMillen IC; Duffield JA; Brooks DA; Morrison JL
Metabolism; 2013 Nov; 62(11):1662-72. PubMed ID: 23928106
[TBL] [Abstract][Full Text] [Related]
8. Regulation of sarcolemmal transport of substrates in the healthy and diseased heart.
Glatz JF; Bonen A; Ouwens DM; Luiken JJ
Cardiovasc Drugs Ther; 2006 Dec; 20(6):471-6. PubMed ID: 17119873
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes.
Steinbusch LK; Dirkx E; Hoebers NT; Roelants V; Foretz M; Viollet B; Diamant M; van Eys G; Ouwens DM; Bertrand L; Glatz JF; Luiken JJ
J Mol Cell Cardiol; 2013 Feb; 55():165-73. PubMed ID: 23159540
[TBL] [Abstract][Full Text] [Related]
10. A novel protein kinase C target site in protein kinase D is phosphorylated in response to signals for cardiac hypertrophy.
Phan D; Stratton MS; Huynh QK; McKinsey TA
Biochem Biophys Res Commun; 2011 Jul; 411(2):335-41. PubMed ID: 21726532
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart.
Lehman JJ; Kelly DP
Clin Exp Pharmacol Physiol; 2002 Apr; 29(4):339-45. PubMed ID: 11985547
[TBL] [Abstract][Full Text] [Related]
12. Emergency Spatiotemporal Shift: The Response of Protein Kinase D to Stress Signals in the Cardiovascular System.
Wood BM; Bossuyt J
Front Pharmacol; 2017; 8():9. PubMed ID: 28174535
[TBL] [Abstract][Full Text] [Related]
13. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure.
Zhang T; Brown JH
Cardiovasc Res; 2004 Aug; 63(3):476-86. PubMed ID: 15276473
[TBL] [Abstract][Full Text] [Related]
14. Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake.
Angin Y; Schwenk RW; Nergiz-Unal R; Hoebers N; Heemskerk JW; Kuijpers MJ; Coumans WA; van Zandvoort MA; Bonen A; Neumann D; Glatz JF; Luiken JJ
Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E225-36. PubMed ID: 24895286
[TBL] [Abstract][Full Text] [Related]
15. Signalling components involved in contraction-inducible substrate uptake into cardiac myocytes.
Luiken JJ; Coort SL; Koonen DP; Bonen A; Glatz JF
Proc Nutr Soc; 2004 May; 63(2):251-8. PubMed ID: 15294039
[TBL] [Abstract][Full Text] [Related]
16. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
17. PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway.
Zhao D; Wang W; Wang H; Peng H; Liu X; Guo W; Su G; Zhao Z
Int J Biol Sci; 2017; 13(3):276-285. PubMed ID: 28367092
[TBL] [Abstract][Full Text] [Related]
18. Differential induction of protein kinase C isoforms at the cardiac hypertrophy stage and congestive heart failure stage in Dahl salt-sensitive rats.
Koide Y; Tamura K; Suzuki A; Kitamura K; Yokoyama K; Hashimoto T; Hirawa N; Kihara M; Ohno S; Umemura S
Hypertens Res; 2003 May; 26(5):421-6. PubMed ID: 12887134
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Purushothaman S; Sathik MM; Nair RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-independent effects of protein kinase D3 in glucose transport in L6 myotubes.
Chen J; Lu G; Wang QJ
Mol Pharmacol; 2005 Jan; 67(1):152-62. PubMed ID: 15496505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
